Novartis | NOVN - Satış Gelirleri

Hisse Senedi Fiyatı
112.78
Günlük Değişim
-1.94 -1.69%
Aylık
-5.88%
Yıllık
20.25%
Q2 Tahmin
111.47




Satış Değişiklik Tarih
AbbVie USD 15B 1.62B 2026-03
Alcon AG USD 2.7B 110M 2025-12
Almirall EUR 547.63M 12.83M 2025-12
Amgen USD 9.9B 340M 2025-12
AstraZeneca USD 15.29B 213M 2026-03
Autolus Therapeutics Ltd USD 24.29M 1.68M 2025-12
Bayer EUR 11.44B 1.78B 2025-12
Biogen USD 2.25B 30M 2026-03
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Fresenius EUR 5.88B 400M 2025-12
Fresenius Medical Care EUR 5.07B 180M 2025-12
Galapagos EUR 900.82M 835.52M 2025-12
Genmab DKK 1.06B 36M 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 7.63B 991M 2026-03
GRIFOLS EUR 1.98B 110M 2025-12
Hikma Pharmaceutical USD 1.69B 863M 2025-12
J&J USD 24.1B 500M 2026-03
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.25B 70M 2025-12
Merck USD 16.4B 880M 2025-12
Novartis USD 13.11B 226M 2026-03
Novartis USD 13.11B 750M 2026-03
Novo Nordisk DKK 79.14B 4.16B 2025-12
Orion EUR 417.7M 277.6M 2026-03
Pfizer USD 17.58B 880M 2025-12
Philips EUR 5.1B 797M 2025-12
Recordati EUR 662M 37.65M 2025-12
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
UCB EUR 4.25B 764M 2025-12